Investment Partnership / US Transatlantic Trade / /
Continent
America / Europe / /
Country
Germany / France / United States / United Kingdom / /
Currency
EUR / / /
Event
Product Recall / Product Issues / /
Facility
National Institute / Massachusetts Institute of Technology / /
IndustryTerm
social insurance systems / healthcare policymakers / social insurance bodies / pharmaceutical and medical devices industry / pharmaceutical industry / pharmaceutical / online questionnaire / pharmaceutical regulatory framework / medicinal products / not-for-profit health insurance / public health insurance systems / social security systems / informal network / healthcare payers / online questioner / medicinal product / health systems / health technology assessments / privatise pharmaceutical knowledge / pharmaceutical and medical devices / /
MIT Center for Biomedical Innovation / Food and Drug Administration / Transparency Commission / Massachusetts Institute of Technology / European Parliament / Human Medicines Research & Development Support Division / European Medicine Agency / CHMP / Scientific Advice Working Party / EMA’s Scientific Advice Working Party / EMA HTA / International Society of Drug Bulletins / Nordic Cochrane Centre / MIT Center for International Studies / European Commission / Drug Regulatory Agency / European Federation of Pharmaceutical Industry and Associations / European Union / Health Technology Assessment / Center for Biomedical Innovation / Committee for Medicinal Products / Federal Joint Committee / National Institute for Clinical Excellence / /
Person
Richard Bergström / Eichler / /
Position
chief medical officer / director / Senior EMA official / /
Product
pioglitazone / medicine / Vioxx / ibuprofen / /
ProgrammingLanguage
EC / /
ProvinceOrState
Massachusetts / /
PublishedMedium
Official Journal of the European Union / /
RadioStation
CBI / /
Technology
Health Technology / 1 Health Technology / drug development / /
Brussels, 14 July 2014 Joint response to EMA’s public consultation on its “Best practice guidance for Pilot EMA HTA parallel scientific advices procedures” Parallel scientific advice: the first step towards undermi